Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Infigratinib for unresectable locally advanced or metastatic cholangiocarinoma with FGFR2 rearrangements – second line	Infigratinib (BGJ398; BGJ-398; Truseltiq)	Cholangiocarcinoma	Gastrointestinal Cancer	2021	View \| Download
Inhaled Lipid‐complexed Cisplatin for Pulmonary Relapse of Osteosarcoma	Cisplatin SR (Cisplatin liposomal inhaled)	Bone sarcoma	Sarcoma	2018	View \| Download
Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease including combined pulmonary fibrosis and emphysema	Treprostinil (Tyvaso; LIQ861; Orenitram; UT-15C; Remodulin; treprostinil sodium)	Pulmonary hypertension	Cardiovascular System , Respiratory System	2024	View \| Download
Inolimomab for acute Graft versus Host Disease	Inolimomab (Leukotac; B-B10; BT563)	Graft versus host disease (GvHD)	Immunology	2021	View \| Download
Insulin icodec for treating Type 1 and Type 2 diabetes	Insulin icodec	Type 1 diabetes , Type 2 diabetes	Endocrine Nutritional and Metabolic Disorders	2022	View \| Download
Intravenous Doxorubicin Nanoparticles for Advanced Hepatocellular Carcinoma	Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2017	View \| Download
Invimestrocel for Acute ischaemic stroke	Multistem(PF05285401;HLCM05;invimestrocel)	Acute ischaemic stroke	Cardiovascular System	2023	View \| Download
Iomab-B for active, relapsed or refractory acute myeloid leukaemia in older patients (aged 55 years and older)	I-131-Apamistamab (Iomab-B)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2017	View \| Download
Ipatasertib in addition to paclitaxel for locally advanced or metastatic triple-negative breast cancer	Ipatasertib (GDC-0068; RG7440) , Paclitaxel (Taxol; paclitaxel albumin)	Breast cancer	Breast Cancer	2020	View \| Download
Ipatasertib in combination with abiraterone and prednisone for metastatic castrate resistant prostate cancer – first line	Abiraterone acetate (Zytiga; Yonsa) , Ipatasertib (GDC-0068; RG7440) , Prednisone (Decadron; Lodotra)	Prostate cancer	Male Reproductive Cancer	2020	View \| Download